Riboflavin depletion impairs cell proliferation in adult human duodenum: Identification of potential effectors

Digestive Diseases and Sciences

Volumn 56, Issue 4, 2011, Pages 1007-1019

  Nakano, Emi ^a   Mushtaq, Sohail ^a   Heath, Paul R ^a   Lee, Eun Sook ^a   Bury, Jonathan P ^a   Riley, Stuart A ^b   Powers, Hilary J ^a   Corfe, Bernard M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Intestine; Mitosis; Proliferation; Riboflavin

Indexed keywords

ASPM PROTEIN; BIRC5 PROTEIN; CYCLIN B1; KIF23 PROTEIN; PROTEIN; RIBOFLAVIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BLOOD SAMPLING; CELL DIVISION; CELL PROLIFERATION; CLINICAL ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; DUODENUM; DUODENUM BIOPSY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GASTROSCOPY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; MITOSIS; MORPHOLOGY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RIBOFLAVIN DEFICIENCY;

ADULT; AGED; CACO-2 CELLS; CELL PROLIFERATION; CROSS-SECTIONAL STUDIES; CYCLIN B1; DOWN-REGULATION; DUODENUM; FEMALE; GASTROSCOPY; GENE EXPRESSION PROFILING; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; RIBOFLAVIN DEFICIENCY; UP-REGULATION;

EID: 79955626609     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1374-3     Document Type: Article

References (40)

1. Gastaldi G, Ferrari G, Verri A, Casirola D, Orsenigo MN, Laforenza U. Riboflavin phosphorylation is the crucial event in riboflavin transport by isolated rat enterocytes. J Nutr. 2000;130:2556-2561.
2. Hoppel CL, Tandler B. Riboflavin and mouse hepatic cell structure and function. Mitochondrial oxidative metabolism in severe deficiency states. J Nutr. 1975;105:562-570.
3. Tu BP, Ho-Schleyer SC, Travers KJ, Weissman JS. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science. 2000;290:1571-1754.
4. Williams EA, Rumsey RD, Powers HJ. An investigation into the reversibility of the morphological and cytokinetic changes seen in the small intestine of riboflavin deficient rats. Gut. 1996;39:220-225. (Pubitemid 26275999)
5. Williams EA, Rumsey RD, Powers HJ. Cytokinetic and structural responses of the rat small intestine to riboflavin depletion. Br J Nutr. 1996;75:315-324. (Pubitemid 26085252)
6. Yates CA, Evans GS, Powers HJ. Riboflavin deficiency: early effects on post-weaning development of the duodenum in rats. Br J Nutr. 2001;86:593-599. (Pubitemid 33138263)
7. Powers HJ, Weaver LT, Austin S, Beresford JK. A proposed intestinal mechanism for the effect of riboflavin deficiency on iron loss in the rat. Br J Nutr. 1993;69:553-561. (Pubitemid 23105491)
8. Williams EA, Powers HJ, Rumsey RD. Morphological changes in the rat small intestine in response to riboflavin depletion. Br J Nutr. 1995;73:141-146.
9. Yates CA, Evans GS, Pearson T, Powers HJ. Absence of luminal riboflavin disturbs early postnatal development of the gastrointestinal tract. Dig Dis Sci. 2003;48:1159-1164.
10. Powers HJ, Corfe BM, Nakano E (2010) Riboflavin in development and cell fate. In: Stanger O Springer (ed) Water soluble vitamins (in press).
11. Camporeale G, Zempleni J. Oxidative folding of interleukin-2 is impaired in flavin-deficient jurkat cells, causing intracellular accumulation of interleukin-2 and increased expression of stress response genes. J Nutr. 2003;133:668-672. (Pubitemid 36268337)
12. Manthey KC, Chew YC, Zempleni J. Riboflavin deficiency impairs oxidative folding and secretion of apolipoprotein B-100 in HepG2 cells, triggering stress response systems. J Nutr. 2005;135:978-982. (Pubitemid 40638294)
13. Manthey KC, Rodriguez-Melendez R, Hoi JT, Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J Nutr Biochem. 2006;17:250-256. Epub 2005 Jun 13.
14. Werner R, Manthey KC, Griffin JB, Zempleni J. HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium. J Nutr Biochem. 2005;16:617-624. (Pubitemid 41338374)
15. Scaife RM. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium. Mol Cancer Ther. 2004;3:1229-1237. (Pubitemid 39440168)
16. Igase M, Okura T, Nakamura M, Takata Y, Kitami Y, Hiwada K. Role of GADD153 (growth arrest- and DNA damage-inducible gene 153) in vascular smooth muscle cell apoptosis. Clin Sci (Lond). 2001;100:275-281. (Pubitemid 32215998)
17. Siassi F, Ghadirian P. Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran. Cancer Detect Prev. 2005;29:464-469. (Pubitemid 41406142)
18. Brun TA, Chen J, Campbell TC, et al. Urinary riboflavin excretion after a load test in rural China as a measure of possible riboflavin deficiency. Eur J Clin Nutr. 1990;44:195-206. (Pubitemid 20153165)
19. Lakshmi AV. Riboflavin metabolism-relevance to human nutrition. Indian J Med Res. 1998;108:182-190.
20. Shaw NS. Riboflavin status in late pregnancy, postpartum and cord blood. Nutr Res. 1993;13:147-155.
21. Bates CJ, Powers HJ, Downes R, Brubacher D, Sutcliffe V, Thurnhill A. Riboflavin status of adolescent vs. elderly Gambian subjects before and during supplementation. Am J Clin Nutr. 1989;50:825-829. (Pubitemid 19252743)
22. Gregory J, Lowe S (2000) National Diet and Nutrition Survey. Young people aged 4-18 years: report of the diet and nutrition survey. The Stationery Office.
23. Lopez R, Schwartz JV, Cooperman JM. Riboflavin deficiency in an adolescent population in New York City. Am J Clin Nutr. 1980;33:1283-1286. (Pubitemid 10017476)
24. Ten State Nutrition Survey, Education and Welfare Publication number (HSM) 72-8134. Dept of Health, 1971.
25. Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL (2002) Dietary intake of macronutrients, micronutrients, and other dietary constituents: United States, 1988-94. National Center for Health Statistics.
26. Powers HJ, Weaver LT, Austin S, Wright AJ, Fairweather-Tait SJ. Riboflavin deficiency in the rat: effects on iron utilisation and loss. Brit J Nutr. 1991;65(Suppl 3):487-496.
27. Fairweather-Tait SJ, Powers HJ, Minski MJ, Whitehead J, Downes R. Riboflavin deficiency and iron absorption in adult Gambian men. Ann Nutr Metab. 1992;36(Suppl 1):34-40.
28. Hill MHE, Bradley A, Mushtaq S, Williams EA, Powers HJ. Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione reductase activation coefficient. Br J Nutr. 2009;102:273-278.
29. Capo-chichi CD, Gueant JL, Feillet F, Namour F, Vidailhet M. Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2000;739:219-224. (Pubitemid 30105687)
30. Chirakkal H, Leech SH, Brookes KE, Prais AL, Waby JS, Corfe BM. Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene. 2006;25:7192-7200. (Pubitemid 44764188)
31. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics. 2007;23:3251-3253. (Pubitemid 350187532)
32. Livak KJ, Schmittgen TD. Analysis of gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(Suppl 4):402-408. (Pubitemid 34164012)
33. Said HM, Ma TY, Ortiz A, Moyer MP, Yanagawa N. Mechanism of riboflavin uptake by Caco-2 human intestinal epithelial cells. Am J Physiol. 1994;266:G15-G21.
34. Ding QM, Ko TC, Evers BM. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am J Physiol. 1998;275:C1193-C1200.
35. Aliaga JC, Deschenes C, Beaulieu JF, Calvo EL, Rivard N. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol. 1999;277:G631-G641. (Pubitemid 29458237)
36. Manthey KC, Rodriguez-Melendez R, Hoi JT, Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J Nutr Biochem. 2006;17:250-256.
37. Avides MD, Glover DM. Abnormal spindle protein, asp, and the integrity of mitotic centrosomal microtubule organizing centers. Science. 1999;283:1733-1735.
38. Kouprina N, Pavlicek A, Collins NK, et al. The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein. Hum Mol Genet. 2005;14:2155-2165. (Pubitemid 41418015)
39. Sullivan M, Morgan DO. Finishing mitosis, one step at a time. Nature Rev Mol Cell Biol. 2007;8:894-903. (Pubitemid 47622563)
40. De Vega L, Perez Fernandez R, Martin Mateo MC, et al. Study of the activity of glutathione-peroxidase, glutathione-transferase and glutathione reductase in renal transplants. Transplant Proc. 2003;35(Suppl 4):1346-1350.